Sunday, March 12, 2023, 8:00 – 10:00 AM
Ernest N. Morail Convention Center
How to Report and Categorize Difficult Cases Utilizing the WHO-IARC-IAC International Systems for Reporting Cytopathology
The International Academy of Cytology has joined with the International Agency for Research into Cancer (IARC), a WHO publishing arm, in developing and publishing four international systems for reporting lung, pancreaticobiliary, lymph node and soft tissue cytopathology. The goals of this project are to improve and standardize the reporting of cytopathology, improve communication between cytopathologists and clinicians, improve patient care, focus on the current role of cytopathology at these sites and highlight areas requiring further research.
This course will present four difficult cytology cases of lung, pancreaticobiliary, lymph node and soft tissue and describe how to approach them using the WHO-IARC-IAC International Systems for Reporting Cytopathology. For each case it will be shown how to report them, diagnostic criteria, risk of malignancy, use of ancillary technique and respective management.
Upon completion of this educational activity, the learner will be able to:
- Use the WHO-IARC-IAC International Systems for Reporting Cytopathology to handle difficult cases in the daily routine.
- Describe the nomenclature systems for reporting lung, pancreatobiliary, soft tissue and lymph node cytology findings.
- Discuss the management of each category in the four systems described.
CHAIRS
Andrew S. Field, Professor, MBBS, FIAC, FRCPA, University of NSW, Notre Dame University Medical Schools, Sydney, Australia
Fernando Schmitt, MD, PhD, FIAC, Medical Faculty of Porto University, Portugal
Introduction WHO-IARC-IAC International Systems for Reporting Cytopathology
Fernando Schmitt, MD, PhD, FIAC, Medical Faculty of Porto University
Pancreatobiliary Cytology
Barbara Ann Centeno, MD, MIAC, H. Lee Moffitt Cancer Center & Research Institute
Lung Cytology
Sinchita Roy-Chowdhuri, MD, PhD, The University of Texas MD Anderson Cancer Center
Soft Tissue Cytology
Ivan Chebib, MD, FRCPC, Massachusetts General Hospital, Harvard Medical School
Final Remarks and Discussion
Andrew S. Field, Professor, MBBS, FIAC, FRCPA, University of NSW, Notre Dame University Medical Schools, Sydney